{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T21:24:21Z","timestamp":1787261061842,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013017","name":"Vanderbilt University Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013017","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.humpath.2024.105682","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T11:45:34Z","timestamp":1731671134000},"page":"105682","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Validation of Keratin 17 as a tissue biomarker in the diagnosis of upper tract urothelial carcinoma"],"prefix":"10.1016","volume":"154","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4196-9307","authenticated-orcid":false,"given":"Woodson","family":"Smelser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sholeh","family":"Jahanfard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Sarno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam S.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna A.","family":"Giannico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2024.105682_bib1","first-page":"233","article-title":"Colorectal cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"Ca - Cancer J Clin"},{"key":"10.1016\/j.humpath.2024.105682_bib2","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/j.1464-410X.2006.06524.x","article-title":"Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: time to change the treatment paradigm?","volume":"98","author":"Brown","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.humpath.2024.105682_bib3","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/cncr.20395","article-title":"Synchronous bilateral ureteral and renal pelvic carcinomas: incidence, etiology, treatment and outcome","volume":"101","author":"Holmang","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2024.105682_bib4","unstructured":"National Comprehensive Cancer Network. Bladder Cancer (Version 3.2023). Pg 40."},{"key":"10.1016\/j.humpath.2024.105682_bib5","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0022-5347(17)43119-3","article-title":"Flexible ureteropyeloscopy: diagnosis and treatment in the upper urinary tract","volume":"138","author":"Bagley","year":"1987","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2024.105682_bib6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.clgc.2021.10.002","article-title":"Discordance between clinical and pathological staging and grading in upper tract urothelial carcinoma","volume":"20","author":"Mori","year":"2022","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.humpath.2024.105682_bib7","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/dc.24127","article-title":"The utility of upper urinary tract urine cytology before and after application of the Paris system","volume":"47","author":"Simon","year":"2019","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.humpath.2024.105682_bib8","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/modpathol.2013.166","article-title":"Keratin 17 in premalignant and malignant squamous lesions of the cervix: proteomic discovery and immunohistochemical validation as a diagnostic and prognostic biomarker","volume":"27","author":"Escobar-Hoyos","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2024.105682_bib9","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41379-018-0177-5","article-title":"Keratin 17 is a sensitive and specific biomarker of urothelial neoplasia","volume":"32","author":"Babu","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2024.105682_bib10","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1007\/s10120-017-0712-y","article-title":"Knockdown of KRT17 by siRNA induces antitumoral effects on gastric cancer cells","volume":"20","author":"Chivu-Economescu","year":"2017","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.humpath.2024.105682_bib11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.humpath.2016.10.006","article-title":"Keratin 17 is overexpressed and predicts poor survival in estrogen receptor-negative\/human epidermal growth factor receptor-2-negative breast cancer","volume":"62","author":"Merkin","year":"2017","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2024.105682_bib12","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1002\/hed.25164","article-title":"Elevated expression of keratin 17 in oropharyngeal squamous cell carcinoma is associated with decreased survival","volume":"40","author":"Regenbogen","year":"2018","journal-title":"Head Neck"},{"key":"10.1016\/j.humpath.2024.105682_bib13","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1007\/s13277-013-0703-5","article-title":"Overexpression of keratin 17 is associated with poor prognosis in epithelial ovarian cancer","volume":"34","author":"Wang","year":"2013","journal-title":"Tumour Biol"},{"key":"10.1016\/j.humpath.2024.105682_bib14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ceb.2012.10.018","article-title":"The expanding significance of keratin intermediate filaments in normal and diseased epithelia","volume":"25","author":"Pan","year":"2013","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.humpath.2024.105682_bib15","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/path.5178","article-title":"Keratin 17 in disease pathogenesis: from cancer to dermatoses","volume":"247","author":"Yang","year":"2019","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2024.105682_bib16","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1038\/jid.2011.222","article-title":"IL-17A upregulates keratin 17 expression in keratinocytes through STAT1- and STAT3-dependent mechanisms","volume":"131","author":"Shi","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.humpath.2024.105682_bib17","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/carcin\/bgz192","article-title":"KRT17 as a prognostic biomarker for stage II colorectal cancer","volume":"41","author":"Ujiie","year":"2020","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.humpath.2024.105682_bib18","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.humpath.2019.09.005","article-title":"Keratin 17 is a negative prognostic biomarker in high-grade endometrial carcinomas","volume":"94","author":"Bai","year":"2019","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2024.105682_bib19","first-page":"5695","article-title":"Overexpression of cytokeratin 17 is associated with the development of papillary thyroid carcinoma and the presence of lymph node metastasis","volume":"8","author":"Kim","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.humpath.2024.105682_bib20","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1128\/MCB.00241-13","article-title":"A novel role for keratin 17 in coordinating oncogenic transformation and cellular adhesion in Ewing sarcoma","volume":"33","author":"Sankar","year":"2013","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.humpath.2024.105682_bib21","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/PAI.0000000000000862","article-title":"Keratin 17 expression predicts poor clinical outcome in patients with advanced esophageal squamous cell carcinoma","volume":"29","author":"Haye","year":"2021","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.humpath.2024.105682_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/biom12091183","article-title":"Reduced expression of KRT17 predicts poor prognosis in HER2(high) breast cancer","volume":"12","author":"Tang","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.humpath.2024.105682_bib23","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1210\/jc.2002-021353","article-title":"Sex steroid hormone receptors in human thymoma","volume":"88","author":"Ishibashi","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.humpath.2024.105682_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02915089","article-title":"Immunohistochemical localization of cytokeratin 17 in transitional cell carcinomas of the human urinary tract","volume":"64","author":"Guelstein","year":"1993","journal-title":"Virchows Arch B Cell Pathol Incl Mol Pathol"},{"key":"10.1016\/j.humpath.2024.105682_bib25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-1-4939-7234-0_5","article-title":"Molecular subtype profiling of urothelial carcinoma using a subtype-specific immunohistochemistry panel","volume":"1655","author":"Sjodahl","year":"2018","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.humpath.2024.105682_bib26","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","article-title":"A consensus molecular classification of muscle-invasive bladder cancer","volume":"77","author":"Kamoun","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.humpath.2024.105682_bib27","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1097\/00000478-200108000-00013","article-title":"Discriminatory immunohistochemical staining of urothelial carcinoma in situ and non-neoplastic urothelium: an analysis of cytokeratin 20, p53, and CD44 antigens","volume":"25","author":"McKenney","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2024.105682_bib28","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.acuro.2022.02.004","article-title":"A systematic review and meta-analysis of CK20, CD44, Ki67 and p53 as immunohistochemical markers in bladder carcinoma in situ","volume":"46","author":"Straccia","year":"2022","journal-title":"Actas Urol Esp"},{"key":"10.1016\/j.humpath.2024.105682_bib29","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1097\/PAS.0000000000000240","article-title":"Best practices recommendations in the application of immunohistochemistry in the bladder lesions: report from the International Society of Urologic Pathology consensus conference","volume":"38","author":"Amin","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2024.105682_bib30","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/01.MP.0000056628.38714.5D","article-title":"Immunohistochemical expression of CK20, p53, and Ki-67 as objective markers of urothelial dysplasia","volume":"16","author":"Mallofre","year":"2003","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2024.105682_bib31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1746-1596-4-35","article-title":"Utility of a dual immunostain cocktail comprising of p53 and CK20 to aid in the diagnosis of non-neoplastic and neoplastic bladder biopsies","volume":"4","author":"Yildiz","year":"2009","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.humpath.2024.105682_bib32","doi-asserted-by":"crossref","first-page":"64","DOI":"10.5858\/arpa.2016-0411-OA","article-title":"CK20 and p53 immunohistochemical staining patterns in urinary bladder specimens with equivocal atypia","volume":"142","author":"Arias-Stella","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2024.105682_bib33","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.humpath.2020.02.008","article-title":"Immunohistochemical staining patterns of Ki-67 and p53 in florid reactive urothelial atypia and urothelial carcinoma in situ demonstrate significant overlap","volume":"98","author":"Nguyen","year":"2020","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2024.105682_bib34","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/his.12360","article-title":"Uroplakin II outperforms uroplakin III in diagnostically challenging settings","volume":"65","author":"Smith","year":"2014","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2024.105682_bib35","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1309\/AJCP1J0JPJBPSUXF","article-title":"Uroplakin II is a more sensitive immunohistochemical marker than uroplakin III in urothelial carcinoma and its variants","volume":"142","author":"Li","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2024.105682_bib36","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.humpath.2020.01.004","article-title":"The applicability and utility of immunohistochemical biomarkers in bladder pathology","volume":"98","author":"Akgul","year":"2020","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2024.105682_bib37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/PAS.0b013e3182a0218f","article-title":"GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors","volume":"38","author":"Miettinen","year":"2014","journal-title":"Am J Surg Pathol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817724001916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817724001916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T20:31:31Z","timestamp":1787257891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817724001916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":37,"alternative-id":["S0046817724001916"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2024.105682","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation of Keratin 17 as a tissue biomarker in the diagnosis of upper tract urothelial carcinoma","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2024.105682","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105682"}}